Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
54
# OF OVERLAPPING
HOLDINGS
IBB
252
HOLDINGS
25%
ALSO IN BBP
BBP
63
HOLDINGS
87%
ALSO IN IBB
SECTOR DRIFT (IBB minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 7.0% | 1.6% | 1.6% |
|
INCYTE CORP | 1.7% | 1.6% | 1.6% |
|
AMGEN INC | 7.3% | 1.6% | 1.6% |
|
GILEAD SCIENCES INC | 7.2% | 1.6% | 1.6% |
|
BIOGEN IDEC INC | 2.5% | 1.6% | 1.6% |
IBB Overweight Relative to BBP
|
AMGEN INC | 5.7% |
|
GILEAD SCIENCES INC | 5.6% |
|
VERTEX PHARMACEUTICALS INC | 5.6% |
|
REGENERON PHARMACEUTICALS | 5.3% |
 |
ARGENX SE ADR | 3.3% |
|
NATERA INC | 2.4% |
|
REVOLUTION MEDICINES, INC. | 2.1% |
|
ALNYLAM PHARMACEUTICALS INC | 2.1% |
|
ILLUMINA INC | 1.7% |
|
INSMED INC | 1.2% |
IBB Underweight Relative to BBP
|
DYNAVAX TECHNOLOGIES CORP | -2.2% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -1.7% |
|
PHATHOM PHARMACEUTICALS, INC. | -1.7% |
|
AMICUS THERAPEUTICS INC | -1.7% |
|
LIGAND PHARMACEUTICALS-CL B | -1.6% |
|
NUVATION BIO INC CLASS A | -1.6% |
 |
THERAVANCE BIOPHARMA INC | -1.5% |
|
KURA ONCOLOGY, INC. | -1.5% |
|
ASCENDIS PHARMA A/S | -1.5% |